Sghealthcare

At a glance

Sghealthcare filed 31 disclosures in the last 12 months, including 3 insider. The most recent key filing was on Jul 9.

Revenue for 2025 was ₩24.6B, up 52.8% on 2024. Operating margin was 6% against -4.2% a year earlier. Debt was 66% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩9.1B and operating loss of ₩588.4M.

The 2025 annual report lists 39 employees with an average tenure of 3.5 years and average pay of ₩53.3M. Its 6 directors and auditors were paid ₩73M each on average. It paid no cash dividend for 2025. 김정수 and related parties held 32.95% at year end.

From the 2025 annual report

Staff: 39 (26 men, 13 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩2.1B. Directors and auditors: 6, paid ₩443M in total.

No cash dividend was paid for 2025.

Largest shareholder

김정수 holds 30.03%; with 1 related party the group holds 32.95% of common shares at year end (from 33.55% at the start of the year).

Auditor: 태일회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary